Predicting Drug Solubility Using Different Machine Learning Methods -- Linear Regression Model with Extracted Chemical Features vs Graph Convolutional Neural Network

Predicting the solubility of given molecules is an important task in the pharmaceutical industry, and consequently this is a well-studied topic. In this research, we revisited this problem with the advantage of modern computing resources. We applied two machine learning models, a linear regression model and a graph convolutional neural network model, on multiple experimental datasets. Both methods can make reasonable predictions while the GCNN model had the best performance. However, the current GCNN model is a black box, while feature importance analysis from the linear regression model offers more insights into the underlying chemical influences. Using the linear regression model, we show how each functional group affects the overall solubility. Ultimately, knowing how chemical structure influences chemical properties is crucial when designing new drugs. Future work should aim to combine the high performance of GCNNs with the interpretability of linear regression, unlocking new advances in next generation high throughput screening.

Developing novel ligands with enhanced binding affinity for the sphingosine 1-phosphate receptor 1 using machine learning

Multiple sclerosis (MS) is a debilitating neurological disease affecting nearly one million people in the United States. Sphingosine-1-phosphate receptor 1, or S1PR1, is a protein target for MS. Siponimod, a ligand of S1PR1, was approved by the FDA in 2019 for MS treatment, but there is a demonstrated need for better therapies. To this end, we finetuned an autoencoder machine learning model that converts chemical formulas into mathematical vectors and generated over 500 molecular variants based on siponimod, out of which 25 compounds had higher predicted binding affinity to S1PR1. The model was able to generate these ligands in just under one hour. Filtering these compounds led to the discovery of six promising candidates with good drug-like properties and ease of synthesis. Furthermore, by analyzing the binding interactions for these ligands, we uncovered several chemical properties that contribute to high binding affinity to S1PR1. This study demonstrates that machine learning can accelerate the drug discovery process and reveal new insights into protein-drug interactions.